DRUG-PATHWAY

DRUGs and PATHWAYs

PATHWAY_NAME	REACTOME_ID	KEGG_ID	DRUG_NAME	PUBCHEM_CID	Datasource
Ropivacaine Action Pathway	R-HSA-9639775	0	Ropivacaine	175805	pubchem
The impact of Nsp14 on metabolism	#N/A	#N/A	Migalastat	5886	pubchem
Erlotinib Action Pathway	R-ALL-1173285	0	Erlotinib	176870	pubchem
EGFR tyrosine kinase inhibitor resistance	R-ALL-1216523	map01521	Erlotinib	176870	pubchem
Bilastine H1-Antihistamine Action	R-ALL-9692684	0	Bilastine	185460	pubchem
Latrepirdine H1-Antihistamine Action	R-HSA-9639775	0	Latrepirdine	197033	pubchem
Disease	R-HSA-1643685	0	Lapatinib	208908	pubchem
Diseases of signal transduction by growth factor receptors and second messengers	0	0	Lapatinib	208908	pubchem
Integrated breast cancer pathway	R-HSA-175486	0	Lapatinib	208908	pubchem
Signaling by ERBB2 in Cancer	R-HSA-1227990	0	Lapatinib	208908	pubchem
Drug resistance in ERBB2 KD mutants	R-HSA-9665230	0	Lapatinib	208908	pubchem
Resistance of ERBB2 KD mutants to lapatinib	R-HSA-9665251	0	Lapatinib	208908	pubchem
Disease	R-HSA-1643685	0	Sorafenib	216239	pubchem
Diseases of signal transduction by growth factor receptors and second messengers	0	0	Sorafenib	216239	pubchem
Ferroptosis	R-HSA-9761841	map04216	Sorafenib	216239	pubchem
Sorafenib Metabolism Pathway	R-ALL-9657029	0	Sorafenib	216239	pubchem
Melanoma	Q9UHD0-PRO_0000015379	map05218	Sorafenib	216239	pubchem
Signaling by PDGFR in disease	R-HSA-9671555	0	Sorafenib	216239	pubchem
Drug resistance of PDGFR mutants	R-HSA-9674415	0	Sorafenib	216239	pubchem
Sorafenib-resistant PDGFR mutants	R-HSA-9673718	0	Sorafenib	216239	pubchem